Compared to the placebo, patients treated with Kisunla had a 35% slower cognitive and functional decline at 18 months of ...

Doctors said the drug Kisunla is the first drug to be approved by the FDA for Alzheimer’s in more than a decade giving hope ...

FRESNO, Calif. (KFSN) -- A long-time Fresno doctor is part of a ground-breaking treatment in the fight against Alzheimer's.

Alzheimer’s drug, donanemab (marketed as Kisunla), could be rejected for use by the National Health Service (NHS) in Britain, ...

Several people in fresno were among the first in the nation to receive a new treatment for alzheimer's disease.Now patients ...

As quantitative data replaced qualitative descriptions in the ads, and as information about severe adverse effects was ...

Kisunla (donanemab-azbt) is a prescription drug that’s used to treat Alzheimer’s disease in adults. Kisunla is given as an intravenous (IV) infusion by a doctor or other healthcare professional.

New AI software promises to make diagnosing dementia quicker and more accurate, helping doctors provide timely and effective ...

Kisunla (donanemab-azbt) is a prescription drug that’s used to treat Alzheimer’s disease in adults. This drug currently isn’t known to interact with other drugs. Note: As a person’s ...